Medtronic has been granted a patent for an implantable medical device with therapy circuitry that generates a composite pacing pulse using a series of at least two individual pulses. The device selectively couples capacitors to an output signal line to create pulses with varying peak voltage amplitudes. GlobalData’s report on Medtronic gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Medtronic, Prosthetic cardiac valves was a key innovation area identified from patents. Medtronic's grant share as of January 2024 was 58%. Grant share is based on the ratio of number of grants to total number of patents.
Implantable medical device generating composite pacing pulse with multiple pulses
A recently granted patent (Publication Number: US11883677B2) discloses a medical device designed to deliver a composite pacing pulse for various cardiac applications. The device comprises therapy circuitry with multiple capacitors and an output signal line, capable of generating a composite pacing pulse consisting of a series of at least two individual pulses. These individual pulses are created by selectively coupling different portions of the capacitors to the output signal line, resulting in pulses with varying peak voltage amplitudes and widths. The therapy circuitry can also generate biphasic composite pacing pulses and adjust the number of individual pulses based on a composite pulse width setting.
Furthermore, the patented medical device includes control circuitry to manage pacing escape intervals and deliver the composite pacing pulse in response to specific conditions. The device can be utilized for different types of pacing pulses, including bradycardia pacing, anti-tachycardia pacing, post-shock pacing, asystole pacing, entrainment pulses, and tachyarrhythmia induction pacing. Additionally, the device features a housing with a connector bore for receiving an extra-cardiovascular lead, enhancing its versatility and applicability in clinical settings. Overall, the patented technology offers a sophisticated approach to cardiac pacing, allowing for precise control and customization of pacing pulses to address a variety of cardiac conditions effectively.
To know more about GlobalData’s detailed insights on Medtronic, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
